Population
diabetes mellitus-prone LDLr(-/-)/ApoB(100/100)/IGF-II mouse model
Design
Preclinical
Authors
Loading...
No change to clinical aortic valve management; leaves open metabolic contributions to human calcification pending validation.
The LDLr(-/-)/ApoB(100/100)/IGF-II mouse serves as a novel preclinical model demonstrating that type 2 diabetes and dyslipidemia contribute to early aortic valve calcification.
Quang et al. (2014) studied this question.
Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context: